Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pulm Pharmacol Ther. 2017 Mar 16;44:88–95. doi: 10.1016/j.pupt.2017.03.006

Fig. 2.

Fig. 2

Inhibitor kinetics of 6-alkylsalicylate MG149 on KAT8. A) The velocity of KAT8 was determined at 0 - 20 µM Ac-CoA in the presence of 0, 80, 160 and 240 µM MG149 respectively. Both Km app. and Vmax app decrease at increasing concentrations of MG149. B) The velocity of KAT8 was determined at 0 - 400 µM of the histone substrate (histone H4 peptide) in the presence of 0, 80, 160 and 240 µM MG149 respectively. The Vmax app. is constant at increasing concentrations of MG149, but the Khalf increases. Data shown are representative curves of 3 independent experiments ± SD.